O-GlcNAc regulation of autophagy and α-synuclein homeostasis; implications for Parkinson's disease

Mol Brain. 2017 Jul 19;10(1):32. doi: 10.1186/s13041-017-0311-1.

Abstract

Post-translational modification on protein Ser/Thr residues by O-linked attachment of ß-N-acetyl-glucosamine (O-GlcNAcylation) is a key mechanism integrating redox signaling, metabolism and stress responses. One of the most common neurodegenerative diseases that exhibit aberrant redox signaling, metabolism and stress response is Parkinson's disease, suggesting a potential role for O-GlcNAcylation in its pathology. To determine whether abnormal O-GlcNAcylation occurs in Parkinson's disease, we analyzed lysates from the postmortem temporal cortex of Parkinson's disease patients and compared them to age matched controls and found increased protein O-GlcNAcylation levels. To determine whether increased O-GlcNAcylation affects neuronal function and survival, we exposed rat primary cortical neurons to thiamet G, a highly selective inhibitor of the enzyme which removes the O-GlcNAc modification from target proteins, O-GlcNAcase (OGA). We found that inhibition of OGA by thiamet G at nanomolar concentrations significantly increased protein O-GlcNAcylation, activated MTOR, decreased autophagic flux, and increased α-synuclein accumulation, while sparing proteasomal activities. Inhibition of MTOR by rapamycin decreased basal levels of protein O-GlcNAcylation, decreased AKT activation and partially reversed the effect of thiamet G on α-synuclein monomer accumulation. Taken together we have provided evidence that excessive O-GlcNAcylation is detrimental to neurons by inhibition of autophagy and by increasing α-synuclein accumulation.

Keywords: Akt; Autophagy; Mitochondria; O-GlcNAcylation; Parkinson’s disease; Proteasome; Rapamycin; Thiamet G; mTOR; α-synuclein.

MeSH terms

  • Animals
  • Autophagy* / drug effects
  • Cells, Cultured
  • Glucosamine / metabolism*
  • Glycosylation / drug effects
  • Homeostasis*
  • Humans
  • Models, Biological
  • Neurons / drug effects
  • Neurons / metabolism
  • Parkinson Disease / metabolism*
  • Parkinson Disease / pathology*
  • Phosphorylation / drug effects
  • Postmortem Changes
  • Proto-Oncogene Proteins c-akt / metabolism
  • Pyrans / pharmacology
  • Rats, Sprague-Dawley
  • Signal Transduction / drug effects
  • Sirolimus / pharmacology
  • TOR Serine-Threonine Kinases / metabolism
  • Thiazoles / pharmacology
  • alpha-Synuclein / metabolism*

Substances

  • Pyrans
  • Thiazoles
  • alpha-Synuclein
  • thiamet G
  • Proto-Oncogene Proteins c-akt
  • TOR Serine-Threonine Kinases
  • Glucosamine
  • Sirolimus